              In the United States Court of Federal Claims
                                 OFFICE OF SPECIAL MASTERS
                                          No. 16-832V
                                         (Unpublished)

    ************************* *
                                *
    BRENT OWENS,                *
                                *                         Special Master Katherine E. Oler
                                *
                    Petitioner, *
                                *                         Filed: May 22, 2020
    v.                          *
                                *
    SECRETARY OF HEALTH AND     *
    HUMAN SERVICES,             *                         Petitioner’s Motion for a Decision;
                                *                         Dismissal of Petition; Vaccine Act.
                                *
                    Respondent. *
                                *
    ************************* *

Ronald Homer, Conway, Homer, P.C., Boston, MA, for Petitioner.
Claudia Gangi, U.S. Department of Justice, Washington, DC, for Respondent.

                               DECISION DISMISSING PETITION1

     I.     Procedural History

       On July 13, 2016, Brent Owens (“Petitioner”) filed a petition2 for compensation under the
National Vaccine Injury Compensation Program, 3 alleging that he suffered from Bell’s Palsy as a


1
  Although this Decision has been formally designated “not to be published,” it will nevertheless be posted
on the Court of Federal Claims website in accordance with the E-Government Act of 2002, 44 U.S.C. §
3501 (2012). This means the ruling will be available to anyone with access to the internet. As provided
by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the decision’s inclusion of certain
kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days
within which to request redaction “of any information furnished by that party: (1) that is a trade secret or
commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or
similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine
Rule 18(b). Otherwise, the Decision in its present form will be available. Id.
2
 This case was initial assigned to now-retired Special Master Hastings (ECF No. 4), reassigned to Special
Master Corcoran on October 10, 2017 (ECF No. 29), and then reassigned to my docket on December 5,
2017 (ECF No. 33).
3
 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L.
No. 99-660, 100 Stat. 3755 (codified as amended at 42 U.S.C. §§ 300aa-10–34 (2012)) (hereinafter
“Vaccine Act” or “the Act”). All subsequent references to sections of the Vaccine Act shall be to the
pertinent subparagraph of 42 U.S.C. § 300aa.
result of the flu vaccination he received on October 28, 2014. Pet. at 1, ECF No. 1. Petitioner
filed a statement of completion on July 20, 2016. ECF No. 8.

        On November 10, 2016, Petitioner filed an expert report from Dr. Nizar Souayah. Ex. 15,
ECF No. 23. On November 16, 2017, Respondent filed a responsive expert report from Dr. Peter
Donofrio. Ex. A, ECF No. 31. In this report, Dr. Donofrio states that based on medical providers’
notes, onset of Petitioner’s facial drooping began 24 hours after vaccination, which does not fit the
typical neurologic dysfunction timeline of 7-10 days. Ex. A at 6. On October 3, 2019, I held a
fact hearing to determine the onset of Petitioner’s symptoms. See Transcript of Proceedings held
on October 3, 2019, ECF No. 48. On January 31, 2020, I issued a Ruling on Onset, in which I
found Petitioner’s tongue numbness began on the morning of October 29, 2014 (within 24 hours
of vaccination) and that his facial droop began the morning of October 30, 2014. ECF No. 62. I
ordered the parties to file a joint status report on how they would like to proceed in light of my
Ruling on Onset. See non-PDF Scheduling Order on 2/6/2020. The parties filed a status report on
April 7, 2020 requesting additional time to determine how to proceed. ECF No. 64. I granted that
request. See non-PDF Scheduling Order on 4/7/2020. On May 7, 2020, Petitioner requested an
additional two weeks to file a joint status report. ECF No. 65. I granted that request as well. See
non-PDF Scheduling Order on 5/8/2020.

        On May 21, 2020, Petitioner filed the instant motion to dismiss his petition, stating he “has
been unable to secure further evidence required by the Court to prove entitlement to compensation
in the Vaccine Program.” Pet’r’s Mot. at 1, ECF No. 66.

   II.     Conclusion

         To receive compensation in the Vaccine Program, a petitioner must prove either (1) that
she suffered a “Table Injury” – i.e., an injury falling within the Vaccine Injury Table –
corresponding to her vaccination, or (2) that she suffered an injury that was actually caused by a
vaccine. See §§ 13(a)(1)(A) and 11(c)(1). Moreover, under the Vaccine Act, a petitioner may not
receive a Vaccine Program award based solely on her claims alone. Rather, the petition must be
supported by either medical records or by the opinion of a competent medical expert. § 13(a)(1).
In this case, however, there is insufficient evidence in the record for Petitioner to meet her burden
of proof. Petitioner’s claim therefore cannot succeed and, in accordance with her motion, must be
dismissed. § 11(c)(1)(A).

         As such, IT IS ORDERED THAT,

        Petitioner’s Motion for A Decision Dismissing the Petition is GRANTED and the petition
is hereby DISMISSED. The Clerk shall enter judgment accordingly.

       Any questions regarding this Order may be directed to my law clerk, Sydney Lee, by
telephone at 202-357-6347, or by email at Sydney_Lee@cfc.uscourts.gov.

         IT IS SO ORDERED.
                                                              s/ Katherine E. Oler
                                                              Katherine E. Oler
                                                              Special Master
                                                 2
